Indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults: 🦠 Genotypes 1-6: Universal treatment (no need for genotype testing in resource-limited settings). 🏥 Liver Condition: Effective for patients without cirrhosis or with compensated cirrhosis. ➕ Combinations: Used with Ribavirin for decompensated cirrhosis.

Dosage and administration

Packaging: Bottle of 28 tablets (4-week supply). ⚠️ ADMINISTRATION PROTOCOL: 💊 Dose: Take ONE tablet once daily. Swallow whole (do not chew or crush due to bitter taste). ⏰ Consistency: Take at the same time every day. Never miss a dose. 🍽️ Food: Can be taken with or without food. 📅 Duration: The standard treatment duration is 12 weeks (3 bottles) for most patients.

Pregnancy and breastfeeding. Co-administration with Amiodarone (severe heart risk). Acid Reducers (PPIs): Drugs like Omeprazole reduce Velpatasvir absorption. Take Velakast 4 hours before antacids. Use of St. John’s Wort or Rifampin.

Side effects are generally mild and transient: 🤕 Common: Headache and fatigue are the most reported. 🤢 Gastrointestinal: Mild nausea. Most patients maintain their normal daily routine during treatment.

Velakast — Sofosbuvir 400 mg + 100 mg, 28 pcs, Aprazer

100% original product

Active ingredient

Sofosbuvir Velpatasvir

Manufacturer

Aprazer

Dosage

400 mg + 100 mg

Dosage form Tablets

Tablets per pack 28

Velakast (Sofosbuvir + Velpatasvir) Tablets

Name: Velakast
Brand: Aprazer
SKU: PROD-126
Price: 4157 UAH
Availability: InStock

4157₴ ~~5141₴~~ -19%

Analogues

Velakast Velasof Velpanat Velpanex

Active ingredient

Sofosbuvir Velpatasvir

Manufacturer

Aprazer

Dosage

400 mg + 100 mg

Dosage form Tablets

Tablets per pack 28

Velakast (Sofosbuvir 400 mg + Velpatasvir 100 mg) is a fixed-dose combination generic of Epclusa, manufactured by Aprazer.

Official License: Produced under a license from Gilead Sciences, ensuring it meets the same quality standards as the original US brand. It is a "Pan-Genotypic" Direct-Acting Antiviral (DAA), meaning one pill cures all major strains of Hepatitis C.

Mechanism of Action:

By combining two potent inhibitors (NS5B + NS5A) in a single tablet, Velakast stops the virus from replicating and assembling new particles. It offers a simple, one-pill-a-day regimen.

✅ Efficacy: Cure rates exceeding 98-99% across all genotypes after a 12-week course.

Indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults:

🦠 Genotypes 1-6: Universal treatment (no need for genotype testing in resource-limited settings).
🏥 Liver Condition: Effective for patients without cirrhosis or with compensated cirrhosis.
➕ Combinations: Used with Ribavirin for decompensated cirrhosis.

Packaging: Bottle of 28 tablets (4-week supply).

⚠️ ADMINISTRATION PROTOCOL:

💊 Dose: Take ONE tablet once daily. Swallow whole (do not chew or crush due to bitter taste).
⏰ Consistency: Take at the same time every day. Never miss a dose.
🍽️ Food: Can be taken with or without food.
📅 Duration: The standard treatment duration is 12 weeks (3 bottles) for most patients.

Pregnancy and breastfeeding.
Co-administration with Amiodarone (severe heart risk).
Acid Reducers (PPIs): Drugs like Omeprazole reduce Velpatasvir absorption. Take Velakast 4 hours before antacids.
Use of St. John’s Wort or Rifampin.

Side effects are generally mild and transient:

🤕 Common: Headache and fatigue are the most reported.
🤢 Gastrointestinal: Mild nausea.
Most patients maintain their normal daily routine during treatment.

100% original product

Delivery across Ukraine

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 09.03.2026